TScan Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	133.12	133.36	120.03	161.41	34.79	41.76
Short-Term Investments	138	58.69	-	-	-	-
Cash & Short-Term Investments	271.12	192.04	120.03	161.41	34.79	41.76
Cash Growth	25.85%	60.00%	-25.64%	363.93%	-16.70%	-
Prepaid Expenses	2.97	2.19	4.1	4.25	1.65	0.62
Total Current Assets	274.09	194.24	124.13	165.65	36.45	42.38
Property, Plant & Equipment	67.1	71.23	69.2	17.26	12.53	6.41
Other Long-Term Assets	6.84	6.68	5.76	5.2	0.76	0.6
Total Assets	348.03	272.15	199.09	188.11	49.74	49.38
Accounts Payable	3.65	2.37	2.91	1.77	2.91	1.01
Accrued Expenses	10.93	10.29	6.41	5.51	2.36	0.91
Current Portion of Long-Term Debt	-	3.35	-	-	-	-
Current Portion of Leases	3.9	3.25	3.68	1.65	1.42	0.44
Current Unearned Revenue	9.93	10.14	3.87	11.41	10.63	-
Other Current Liabilities	0.25	0.43	0.43	1.01	0.13	0.03
Total Current Liabilities	28.66	29.82	17.31	21.34	17.45	2.4
Long-Term Debt	30.65	26.7	29.29	-	-	-
Long-Term Leases	55.81	59.14	53.01	4.39	6.02	4.44
Long-Term Unearned Revenue	3.68	5.62	-	1.5	8.82	-
Other Long-Term Liabilities	0.15	-	0.05	0.1	0.24	-
Total Liabilities	118.94	121.28	99.66	27.33	32.52	6.84
Common Stock	0.01	0.01	0	0	0	-
Additional Paid-In Capital	568.37	398.46	257.81	252.93	1.07	0.27
Retained Earnings	-339.29	-247.6	-158.38	-92.16	-43.53	-17.41
Total Common Equity	229.09	150.87	99.43	160.78	-42.46	-17.14
Shareholders' Equity	229.09	150.87	99.43	160.78	17.22	42.54
Total Liabilities & Equity	348.03	272.15	199.09	188.11	49.74	49.38
Total Debt	90.36	92.43	85.98	6.04	7.43	4.89
Net Cash (Debt)	180.76	99.61	34.04	155.36	27.36	36.88
Net Cash Growth	40.74%	192.60%	-78.09%	467.91%	-25.82%	-
Net Cash Per Share	3.39	2.08	1.42	13.32	29.87	95.76
Filing Date Shares Outstanding	53.37	47.88	24.23	23.86	1.14	0.39
Total Common Shares Outstanding	53.35	47.83	24.23	23.91	1.14	0.39
Working Capital	245.43	164.42	106.82	144.31	19	39.98
Book Value Per Share	4.29	3.15	4.10	6.72	-37.38	-44.50
Tangible Book Value	229.09	150.87	99.43	160.78	-42.46	-17.14
Tangible Book Value Per Share	4.29	3.15	4.10	6.72	-37.38	-44.50
Machinery	-	18.63	16.87	12.15	6.14	2.15
Construction In Progress	-	0.55	0.01	1.26	0.78	-
Leasehold Improvements	-	3.16	3.45	3.43	0.49	0.02

Source: S&P Capital IQ. Standard template. Financial Sources.